A n alternative pathway to achieve AOAC Offi cial Methods of Analysis First Action Status was approved by the AOAC Board of Directors on March 28, 2011. Under this path, methods selected and reviewed using the AOAC volunteer consensus standards development processes can be granted Offi cial First Action status by vetted Expert Review Panels (ERPs). Methods approved First Action under the alternative path will remain First Action for a period of about 2 years. During this time, information generated through use of the methods will be monitored. The performance of the methods will be reviewed by the ERPs to determine whether Final Action should be recommended to the Offi cial Methods Board (1) . All methods are reviewed by primary and secondary expert reviewers, then discussed thoroughly by the entire panel, stakeholders, and observers present. Methods are evaluated for completeness of validation and likelihood of meeting standard method performance requirements, including appropriateness for the intended use, clarity of the method description, ruggedness, reproducibility, recovery, analytical range, and LOQ.
Based on the data presented in the single-laboratory validation study (SLV) reported by Campos-Giménez et al. (2) , the method "Determination of Vitamin B 12 in Infant Formulas and Adult Nutritionals by Liquid Chromatography/ UV Detection with Immunoaffi nity Extraction" was granted First Action status and designated AOAC Method 2011.08. The method can be used for the determination of vitamin B 12 , including cyanocobalamin, the form used for fortifi cation, and naturally occurring forms (mainly hydroxy-, adenosyl-, and methylcobalamins), which are predominantly found in meat and dairy products. To estimate the concentration of vitamin B 12 in infant formulas and adult nutritionals containing not only added cyanocobalamin, but also natural forms, the vitamin B 12 is freed from complexing proteins by heating the samples for a short time in the presence of cyanide. The use of an immunoaffi nity extraction step increases selectivity and sensitivity by purifying and concentrating the food extracts. Vitamin B 12 can then be determined by LC with UV detection at 361 nm. LGE (R-Biopharm AG, www.r-biopharm.com; Product Code P88). 
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C. Chemicals and Solvents
E. Sample Preparation and Extraction
Note: Vitamin B 12 is sensitive to light. Conduct operations under subdued light, or use amber glassware. Keep all solutions away from direct light.
(a) Sample preparation for solid samples.-Weigh 50.0 g fi nely ground sample into a 250 mL beaker. Add 100 mL water at 40 ± 5°C, and mix with a glass rod until the suspension is homogeneous, or homogenize with a Polytron. If the sample contains starch, about 0.05 g α-amylase can be added to facilitate handling. Proceed as described in (c) Extraction. support. Open the caps, and let the storage buffer drain by gravity. Close the lower cap. Load the column with 9 mL clear fi ltrate, and close the upper cap. Place the column in a rotary shaker, and mix slowly for 10-15 min. Return the column to the support, and let stand for a few minutes. Open the caps to let the liquid drain by gravity. Wash the column with 10 mL water. With a syringe, insert about 40 mL air to dry the column. Elute with 3 mL methanol, and collect eluate in a 7 mL amber glass reaction vial. Rinse the column with 0.5 mL methanol, and with a syringe insert about 20 mL air to collect all the methanol in the same vial. Evaporate eluate at 50°C under a stream of nitrogen. Reconstitute the sample in 0.3 mL sample dilution solvent. Mix on a vortex mixer. Transfer to a micro amber vial.
(e) System suitability test.-Equilib rate the chromatographic system for ≥1 h. Inject a working standard solution ≥3 times, and check peak retention times and areas. Inject working standard solutions on a regular basis within a series of analyses.
(f) Analysis.-Make single injections of standards and test solutions. Measure chromatographic peak response (height). LC conditions: fl ow rate, 0.25 mL/min; injection volume, 100 mL; detection, UV at 361 nm; and gradient elution (see Table 2011 .08B). 
Results and Discussion
Because approval of this method was achieved under the alternative pathway approved by the AOAC Board of Directors, the method will remain First Action for approximately 2 years while additional information is generated and laboratories have the opportunity to use the method. Data supporting the applicability of this method were published previously by Campos-Giménez et al. (2) . A summary of the results is provided in this paper. Sensitivity was optimized by using a narrow-bore column in combination with a large injection volume (100 mL). Example chromatograms are shown in Figure 1 . The LOD and LOQ were determined by using the S/N approach (S/N = 3). The quantitation limit of the method was evaluated by spiking a nonfortifi ed infant cereal (devoid of vitamin B 12 ) with low amounts of cyanocobalamin, and estimating the value at which quantitation could be achieved with acceptable performance in terms of accuracy and precision. The overall LOD and LOQ were estimated as 0.10 and 0.30 μg/100 g, respectively. The average result obtained when fortifi ed samples were analyzed was 1.47 μg/100 g; the minimum value was 0.43 μg/100 g ( Table 1 ). Eleven concentrations of the standard solution (4-400 ng/mL) were used to establish linearity. Each solution was injected in triplicate. Linear regression analysis was performed, and the determination coeffi cients (R 2 ), as well as residual SDs, were calculated. The values obtained with different combinations of LC systems and columns showed good linearity, confi rmed by an R 2 value of >0.999 and residuals evenly distributed (Table 2 ). Immunoaffi nity cleanup was used to concentrate cyanocobalamin to levels that can be detected in the LC system and to selectively remove compounds other than cyanocobalamin present in the sample extract. The EASY-EXTRACT B 12 LGE columns allow batchwise extraction and yield high recovery and good repeatability between extractions.
The overall method selectivity was demonstrated by comparison of the UV spectra of pure cyanocobalamin standards with the corresponding B 12 chromatographic peak obtained for samples by using two different stationary phases ( Figure 1 ). Accuracy was evaluated through recovery testing by spiking samples with a known amount of vitamin B 12 (cyanocobalamin). Nineteen (n = 19) different samples containing vitamin B 12 in the range of 0.78-5.78 μg/100 g were spiked with an amount of cyanocobalamin equivalent to the content in the native sample. Recovery rates were calculated as:
where C s is the concentration of vitamin B 12 found in the spiked sample, C n is the concentration of vitamin B 12 in the native sample, and C a is the concentration of cyanocobalamin added in the spiked sample. The average recovery from spiked samples was 100.8%, with an SD of 7.5% (Table 3) . The repeatability was evaluated from duplicate analyses of 44 samples containing vitamin B 12 in the range of 0.43-5.78 μg/100 g (different analysts and LC systems). The overall SD of repeatability, S r , was 0.031 μg/100 g, which corresponds to an RSD r of 2.1%. The repeatability was also evaluated using the data from milk-based infant formulas (n = 9; range, 1.13-3.17 μg/100 g) and infant cereals (n = 8; range, 0.75-3.58 μg/100 g); results were S r = 0.042 μg/100 g and RSD r = 2.8%, and S r = 0.037 μg/100 g and RSD r = 3.0%, respectively. The intermediate reproducibility (withinlaboratory, day-to-day variability) was evaluated from duplicate analyses of the same sample on different days, by different analysts, and mainly by using two LC systems. Two samples were chosen, a milk-based infant formula and an infant cereal. The values for SD of intermediate reproducibility, S iR , were 0.073 and 0.043 μg/100 g, respectively, which correspond to RSD iR of 4.3% for both the milk-based infant formula (n = 13; median, 1.69 μg/100 g) and the infant cereal (n = 8; median, 1.00 μg/100 g). The samples were also analyzed in duplicate by the reference microbiological assay (MBA), AOAC 986.23, using Lactobacillus leichmannii (ATCC 7830) as the test microorganism (3) . Values for the RSD r and RSD iR were lower for the LC/UV method than for the MBA (Tables 4 and  5 ). Regression analysis was used for the method comparison because of the relatively wide range of the data set ( Figure 2 ). Despite an R 2 of 0.9442 (indicating a fairly good correlation), a proportional bias (slope statistically different from 1) was detected between the results obtained by the LC method and by the MBA. This discrepancy is most likely due to the larger range of matrixes used in the comparison. The bias obtained is in agreement with the assumption that about 5-30% of the reported vitamin B 12 in foods may be due to the presence of corrinoids that are different from true vitamin B 12 . The MBA response was equivalent to vitamin B 12 at 0.16 μg/100 g, whereas the chromatogram obtained by LC/UV was free from traces of cyanocobalamin ( Figure 1) . Furthermore, the values obtained in analyses of fortifi ed soy-based infant formulas in which only free cyanocobalamin from fortifi cation is present are about 20% higher by MBA than by LC/UV, whereas the LC/UV results agree perfectly with fortifi cation levels (expected cyanocobalamin: 2.36 μg/100 g; Table 6 ). 
